Annual EBITDA
-$150.23 M
-$15.38 M-11.41%
December 31, 2023
Summary
- As of February 7, 2025, KURA annual EBITDA is -$150.23 million, with the most recent change of -$15.38 million (-11.41%) on December 31, 2023.
- During the last 3 years, KURA annual EBITDA has fallen by -$61.38 million (-69.08%).
- KURA annual EBITDA is now -567.20% below its all-time high of -$22.52 million, reached on December 31, 2015.
Performance
KURA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$53.78 M
-$3.56 M-7.08%
September 30, 2024
Summary
- As of February 7, 2025, KURA quarterly EBITDA is -$53.78 million, with the most recent change of -$3.56 million (-7.08%) on September 30, 2024.
- Over the past year, KURA quarterly EBITDA has dropped by -$11.61 million (-27.52%).
- KURA quarterly EBITDA is now -1126.55% below its all-time high of -$4.38 million, reached on March 31, 2015.
Performance
KURA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$195.08 M
-$15.80 M-8.81%
September 30, 2024
Summary
- As of February 7, 2025, KURA TTM EBITDA is -$195.08 million, with the most recent change of -$15.80 million (-8.81%) on September 30, 2024.
- Over the past year, KURA TTM EBITDA has dropped by -$44.85 million (-29.85%).
- KURA TTM EBITDA is now -4348.89% below its all-time high of -$4.38 million, reached on March 31, 2015.
Performance
KURA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KURA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.4% | -27.5% | -29.9% |
| 3 y3 years | -69.1% | -27.5% | -29.9% |
| 5 y5 years | -152.6% | -27.5% | -29.9% |
KURA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.0% | at low | -66.6% | at low | -50.6% | at low |
| 5 y | 5-year | -140.1% | at low | -203.5% | at low | -211.8% | at low |
| alltime | all time | -567.2% | at low | -1126.5% | at low | -4348.9% | at low |
Kura Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$53.78 M(+7.1%) | -$195.08 M(+8.8%) |
| Jun 2024 | - | -$50.23 M(+2.7%) | -$179.28 M(+8.2%) |
| Mar 2024 | - | -$48.89 M(+15.9%) | -$165.63 M(+10.2%) |
| Dec 2023 | -$150.23 M(+11.4%) | -$42.18 M(+11.0%) | -$150.23 M(+6.7%) |
| Sep 2023 | - | -$37.98 M(+3.8%) | -$140.73 M(+1.9%) |
| Jun 2023 | - | -$36.57 M(+9.2%) | -$138.06 M(+1.5%) |
| Mar 2023 | - | -$33.50 M(+2.5%) | -$136.07 M(+0.9%) |
| Dec 2022 | -$134.85 M(+4.1%) | -$32.68 M(-7.5%) | -$134.85 M(+0.1%) |
| Sep 2022 | - | -$35.31 M(+2.1%) | -$134.75 M(+1.6%) |
| Jun 2022 | - | -$34.59 M(+7.2%) | -$132.65 M(+1.0%) |
| Mar 2022 | - | -$32.28 M(-0.9%) | -$131.29 M(+1.4%) |
| Dec 2021 | -$129.49 M(+45.7%) | -$32.58 M(-1.9%) | -$129.49 M(+5.4%) |
| Sep 2021 | - | -$33.21 M(-0.1%) | -$122.82 M(+8.5%) |
| Jun 2021 | - | -$33.23 M(+9.0%) | -$113.17 M(+12.9%) |
| Mar 2021 | - | -$30.48 M(+17.6%) | -$100.27 M(+12.8%) |
| Dec 2020 | -$88.85 M(+42.0%) | -$25.91 M(+10.0%) | -$88.85 M(+10.1%) |
| Sep 2020 | - | -$23.55 M(+15.8%) | -$80.67 M(+10.0%) |
| Jun 2020 | - | -$20.33 M(+6.6%) | -$73.37 M(+8.2%) |
| Mar 2020 | - | -$19.07 M(+7.6%) | -$67.83 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$62.56 M(+5.2%) | -$17.72 M(+9.1%) | -$62.56 M(+3.0%) |
| Sep 2019 | - | -$16.25 M(+9.8%) | -$60.74 M(+2.5%) |
| Jun 2019 | - | -$14.79 M(+7.2%) | -$59.25 M(+0.6%) |
| Mar 2019 | - | -$13.79 M(-13.3%) | -$58.92 M(-0.9%) |
| Dec 2018 | -$59.47 M(+72.3%) | -$15.90 M(+7.8%) | -$59.47 M(+10.0%) |
| Sep 2018 | - | -$14.75 M(+2.0%) | -$54.05 M(+11.7%) |
| Jun 2018 | - | -$14.47 M(+0.9%) | -$48.40 M(+16.5%) |
| Mar 2018 | - | -$14.34 M(+36.7%) | -$41.53 M(+20.3%) |
| Dec 2017 | -$34.52 M(+28.1%) | -$10.49 M(+15.3%) | -$34.52 M(+10.7%) |
| Sep 2017 | - | -$9.10 M(+19.7%) | -$31.17 M(+8.3%) |
| Jun 2017 | - | -$7.60 M(+3.8%) | -$28.79 M(+4.1%) |
| Mar 2017 | - | -$7.32 M(+2.5%) | -$27.66 M(+2.6%) |
| Dec 2016 | -$26.95 M(+19.7%) | -$7.14 M(+6.3%) | -$26.95 M(+2.6%) |
| Sep 2016 | - | -$6.72 M(+4.0%) | -$26.27 M(+1.2%) |
| Jun 2016 | - | -$6.46 M(-2.3%) | -$25.97 M(+3.5%) |
| Mar 2016 | - | -$6.62 M(+2.3%) | -$25.09 M(+9.8%) |
| Dec 2015 | -$22.52 M | -$6.47 M(+0.7%) | -$22.86 M(+39.5%) |
| Sep 2015 | - | -$6.42 M(+15.0%) | -$16.39 M(+64.4%) |
| Jun 2015 | - | -$5.58 M(+27.3%) | -$9.97 M(+127.3%) |
| Mar 2015 | - | -$4.38 M | -$4.38 M |
FAQ
- What is Kura Oncology annual EBITDA?
- What is the all time high annual EBITDA for Kura Oncology?
- What is Kura Oncology annual EBITDA year-on-year change?
- What is Kura Oncology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kura Oncology?
- What is Kura Oncology quarterly EBITDA year-on-year change?
- What is Kura Oncology TTM EBITDA?
- What is the all time high TTM EBITDA for Kura Oncology?
- What is Kura Oncology TTM EBITDA year-on-year change?
What is Kura Oncology annual EBITDA?
The current annual EBITDA of KURA is -$150.23 M
What is the all time high annual EBITDA for Kura Oncology?
Kura Oncology all-time high annual EBITDA is -$22.52 M
What is Kura Oncology annual EBITDA year-on-year change?
Over the past year, KURA annual EBITDA has changed by -$15.38 M (-11.41%)
What is Kura Oncology quarterly EBITDA?
The current quarterly EBITDA of KURA is -$53.78 M
What is the all time high quarterly EBITDA for Kura Oncology?
Kura Oncology all-time high quarterly EBITDA is -$4.38 M
What is Kura Oncology quarterly EBITDA year-on-year change?
Over the past year, KURA quarterly EBITDA has changed by -$11.61 M (-27.52%)
What is Kura Oncology TTM EBITDA?
The current TTM EBITDA of KURA is -$195.08 M
What is the all time high TTM EBITDA for Kura Oncology?
Kura Oncology all-time high TTM EBITDA is -$4.38 M
What is Kura Oncology TTM EBITDA year-on-year change?
Over the past year, KURA TTM EBITDA has changed by -$44.85 M (-29.85%)